SCHEMBL19494637

SCHEMBL19494637

NC(=O)c1cc(SN2CC(F)(F)C2)sc1NC(=O)c1ccccc1F

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.45
▸ RAB9A P51151 7/20 0.45
▸ KDM4E B2RXH2 3/20 0.40
▸ LMNA P02545 3/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ IKBKB O14920 2/20 0.40
▸ MAPT P10636 2/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ HTT P42858 1/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.37
▸ TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494889 0.86 NPC1 (0.48) NPC1RAB9AKDM4ELMNAALDH1A1
SCHEMBL19494717 0.86 NPC1 (0.46) NPC1RAB9AKDM4ELMNAALDH1A1
SCHEMBL19494434 0.85 NPC1 (0.45) NPC1RAB9AKDM4ELMNAALDH1A1
SCHEMBL19494684 0.84 NPC1 (0.46) NPC1RAB9AKDM4ELMNAALDH1A1
SCHEMBL19494729 0.82 NPC1 (0.42) NPC1RAB9AKDM4ELMNAALDH1A1
SCHEMBL19494346 0.81 RAB9A (0.41) NPC1RAB9AKDM4ELMNAALDH1A1
SCHEMBL19494348 0.80 NPC1 (0.47) NPC1RAB9AKDM4ELMNAALDH1A1
SCHEMBL19494506 0.80 NPC1 (0.49) NPC1RAB9AKDM4ELMNAALDH1A1
SCHEMBL19494380 0.79 NPC1 (0.44) NPC1RAB9AKDM4ELMNAALDH1A1
SCHEMBL16246520 0.78 CFTR (0.48) NPC1RAB9AKDM4ELMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback